Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
Keating, Katie M; Brewer, Noel T; Gottlieb, Sami L; Liddon, Nicole; Ludema, Christina; Smith, Jennifer S.
J Adolesc Health
; 43(4 Suppl): S61-7, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18809147
Two Basic Scientists Walk into a Translational Space.
No Vacillation on HPV Vaccination.
A Prize for Cancer Prevention.
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis.
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.